Global Antithrombotic Drugs Market Size, Share & Trends Analysis Report, by Drug Type (Anti-coagulant Drugs, Anti-Fibrinolytics Drugs, and Anti-Platelet Drugs), by Route of Administration (Oral and Parenteral), by Application (Blood Clot And Thromboembolic Treatment Drugs, Hyperlipidemia Treatment, Prophylactic Treatment, Other) Forecast Period (2020-2026)
The global antithrombotic drug market is projected to witness considerable growth during the forecast period. The growing prevalence of chronic diseases across the globe is a key factor responsible for the demand of antithrombotic drugs market across the globe. The growing FDA approvals for different drugs that are used to remove the clotting of blood are further creating a huge opportunity for market growth during the forecast period.
The Antithrombotic drugs market is segmented on the basis of drug type, route of administration, and application. Based on drug type, the market is segmented into anti-coagulant drugs, anti-fibrinolytic drugs, and anti-platelet drugs. Based on the route of administration, the market is segmented into oral, parenteral. Based on the application, the market is segmented into a blood clot and thromboembolic treatment drugs, hyperlipidemia treatment, prophylactic treatment, and others.
Geographically, the global antithrombotic drugs market is classified into North America, Europe, Asia-Pacific, and the Rest of the World. North America is anticipated to have a significant market share in the global market. The growth of the region is being primarily driven by the well-developed healthcare infrastructure of the US. In addition, the presence of the major market players such as Genetech Inc., Pfizer, Inc., Johnson & Johnson among others is another factor attributing towards the growth of the antithrombotic drugs market in the region. Asia-Pacific is estimated to have considerable growth in the global market during the forecast period.
The key players of the antithrombotic drugs market include Novartis International AG, Genetech, Inc., AstraZeneca, Johnson & Johnson Services Inc., Merck KGaA, Pfizer Inc., Boehringer Ingelheim International GmbH, GlaxoSmithKline Plc, Bristol-Myers Squibb, and Eli Lilly and Co., among others. The key market players operating in the thrombotic drug market are actively adopting several strategies such as merger and acquisition, partnerships and collaboration among others.
Research Methodology
The market study of the global antithrombotic drugs market is incorporated by extensive primary and secondary research conducted by the research team. Secondary research has been conducted to refine the available data to breakdown the market in various segments, derive total market size, market forecast, and growth rate. Different approaches have been worked on to derive the market value and market growth rate. The team collects facts and data related to the market from different geography to provide a better regional outlook.
In the report, the country-level analysis is provided by analyzing various regional players, regional tax laws and policies, consumer behavior, and macro-economic factors. Numbers extracted from secondary research have been authenticated by conducting proper primary research. It includes tracking down key people from the industry and interviewing them to validate the data. This enables the analyst to derive the closest possible figures without any major deviations in the actual number. The analysts try to contact as many executives, managers, key opinion leaders, and industry experts. Primary research brings the authenticity of the reports.
Secondary sources include:
The report provides an in-depth analysis of the market size and growth opportunities. The report will serve as a source for 360-degree analysis of the market thoroughly delivering insights into the market for better business decisions.
Market Segmentation:
1. Global Antithrombotic Drugs Market Research and Analysis by Drug Type
2. Global Antithrombotic Drugs Market Research and Analysis by route of administration
3. Global Antithrombotic Drugs Market Research and Analysis by Application
The Report Covers:
The global antithrombotic drug market is projected to witness considerable growth during the forecast period. The growing prevalence of chronic diseases across the globe is a key factor responsible for the demand of antithrombotic drugs market across the globe. The growing FDA approvals for different drugs that are used to remove the clotting of blood are further creating a huge opportunity for market growth during the forecast period.
The Antithrombotic drugs market is segmented on the basis of drug type, route of administration, and application. Based on drug type, the market is segmented into anti-coagulant drugs, anti-fibrinolytic drugs, and anti-platelet drugs. Based on the route of administration, the market is segmented into oral, parenteral. Based on the application, the market is segmented into a blood clot and thromboembolic treatment drugs, hyperlipidemia treatment, prophylactic treatment, and others.
Geographically, the global antithrombotic drugs market is classified into North America, Europe, Asia-Pacific, and the Rest of the World. North America is anticipated to have a significant market share in the global market. The growth of the region is being primarily driven by the well-developed healthcare infrastructure of the US. In addition, the presence of the major market players such as Genetech Inc., Pfizer, Inc., Johnson & Johnson among others is another factor attributing towards the growth of the antithrombotic drugs market in the region. Asia-Pacific is estimated to have considerable growth in the global market during the forecast period.
The key players of the antithrombotic drugs market include Novartis International AG, Genetech, Inc., AstraZeneca, Johnson & Johnson Services Inc., Merck KGaA, Pfizer Inc., Boehringer Ingelheim International GmbH, GlaxoSmithKline Plc, Bristol-Myers Squibb, and Eli Lilly and Co., among others. The key market players operating in the thrombotic drug market are actively adopting several strategies such as merger and acquisition, partnerships and collaboration among others.
Research Methodology
The market study of the global antithrombotic drugs market is incorporated by extensive primary and secondary research conducted by the research team. Secondary research has been conducted to refine the available data to breakdown the market in various segments, derive total market size, market forecast, and growth rate. Different approaches have been worked on to derive the market value and market growth rate. The team collects facts and data related to the market from different geography to provide a better regional outlook.
In the report, the country-level analysis is provided by analyzing various regional players, regional tax laws and policies, consumer behavior, and macro-economic factors. Numbers extracted from secondary research have been authenticated by conducting proper primary research. It includes tracking down key people from the industry and interviewing them to validate the data. This enables the analyst to derive the closest possible figures without any major deviations in the actual number. The analysts try to contact as many executives, managers, key opinion leaders, and industry experts. Primary research brings the authenticity of the reports.
Secondary sources include:
- Financial reports of companies involved in the market
- Whitepapers, research-papers, and news blogs
- Company websites and their product catalog
The report provides an in-depth analysis of the market size and growth opportunities. The report will serve as a source for 360-degree analysis of the market thoroughly delivering insights into the market for better business decisions.
Market Segmentation:
1. Global Antithrombotic Drugs Market Research and Analysis by Drug Type
2. Global Antithrombotic Drugs Market Research and Analysis by route of administration
3. Global Antithrombotic Drugs Market Research and Analysis by Application
The Report Covers:
- Comprehensive research methodology of the global antithrombotic drugs market.
- This report also includes a detailed and extensive market overview with key analyst insights.
- An exhaustive analysis of macro and micro factors influencing the market guided by key recommendations.
- Analysis of regional regulations and other government policies impacting the global antithrombotic drugs market.
- Insights about market determinants which are stimulating the global antithrombotic drugs market.
- Detailed and extensive market segments with regional distribution of forecasted revenues.
- Extensive profiles and recent developments of market players.
Table of Contents
1. Report Summary
2. Market Overview and Insights
3. Competitive Landscape
4. Market Determinants
5. Market Segmentation
6. Regional Analysis
7. Company Profiles
Companies Mentioned
A selection of companies mentioned in this report includes:
- Aspen Pharmacare Holding, Inc.
- AstraZeneca PLC
- Bayer AG
- Boehringer Ingelheim International GmbH
- Bristol-Myers Squibb Co.
- Daiichi Sankyo UK, Ltd.
- Eli Lilly Co.
- Genentech, Inc.
- GlaxoSmithKline Plc
- Glenmark Pharma, Inc.
- Ionis Pharmaceuticals, Inc.
- Johnson & Johnson Service, Inc.
- Merck KgaA
- Novartis International AG
- Otsuka Pharmaceutical Co.
- Pfizer, Inc.
- Sanofi SA
- Sun Pharmaceutical Industries, Ltd.
- Teva Pharmaceuticals USA, Inc.
- Yuyu Pharma, Inc.
